Dr. Wright is a board-certified pediatrician and neonatologist and an Adjunct Professor at George Washington University. She attended the University of Pennsylvania School of Medicine and did her residency and fellowship training at Children's Hospital of Philadelphia. Her interests are in research to improve the health of women and children in the developing world; building research capacity in the developing world; and research to improve the outcome of low-birth-weight infants, especially cognitive outcomes.
As Scientific Officer of two large cooperative agreements, the NICHD Neonatal Research Network and the NIH Global Network for Women's and Children's Health Research, Dr. Wright has been directly involved in more than 50 large randomized controlled trials and studies. The Global Network is a unique partnership between 7 multidisciplinary teams of US and foreign research teams in Asia, Africa, and Latin America whose mission is to improve maternal and child health outcomes by building research capacity and infrastructure, and testing and scaling up cost-effective, sustainable interventions. The Global Network has performed landmark trials in neonatal resuscitation, misoprostol to prevent postpartum hemorrhage, dissemination of best obstetric practices, optimal complementary feeding, and has a unique ongoing birth registry at all GN sites. It is current conducting a trial of a package of interventions to improve Emergency Obstetric and Neonatal Care. Between 1989 and 2003, Dr. Wright was the Scientific Officer for the NICHD Neonatal Research Network, a large US clinical trials group of 16 leading neonatology units which tested interventions to improve the outcome of high-risk neonates, including inhaled nitric oxide for respiratory failure, hypothermia for severe asphyxia, quality improvement, ventilation, and nutritional strategies under her leadership.
Dr. Wright also has been involved in dissemination and implementation research throughout her NIH career: she planned the U.S. Consensus Conference "Effects of Antenatal Corticosteroids for Fetal Maturation on Perinatal Outcomes," which dramatically increased antenatal corticosteroid use to mature preterm fetuses.